A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection
HIV Infections, HIV Seronegativity
About this trial
This is an interventional prevention trial for HIV Infections focused on measuring Vaccines, Synthetic, Viral Vaccines, HIV-1, Dose-Response Relationship, Drug, HIV Envelope Protein gp160, AIDS Vaccines, HIV Seronegativity, Avipoxvirus, Immunization, HIV Envelope Protein gp120, Recombination, Genetic
Eligibility Criteria
Inclusion Criteria Volunteers may be eligible for this study if they: Are HIV-negative. Are in good health. Are between ages 18 and 55. Are available for at least 1 year. Are a resident of the United States of America. Agree to practice sexual abstinence or use birth control. Exclusion Criteria Volunteers will not be eligible for this study if they: Have ever been given an HIV vaccine or certain other vaccines. (However, rabies vaccines are allowed.) Participate in activities that place them at high-risk for HIV infection, such as injection drug use or unprotected sex with someone who has HIV infection. Have certain psychiatric, medical, or substance abuse problems. Are allergic to eggs or other vaccines. Are an employee at a participating site and have access to study information. Are taking certain medications. Have received blood transfusions within 3 months before entering this study. Are pregnant or breast-feeding.
Sites / Locations
- Walter Reed Army Institute of Research